{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:05:16Z","timestamp":1767150316818,"version":"build-2238731810"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychosomatics"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/s0033-3182(10)70722-2","type":"journal-article","created":{"date-parts":[[2011,12,18]],"date-time":"2011-12-18T12:58:00Z","timestamp":1324213080000},"page":"401-408","source":"Crossref","is-referenced-by-count":40,"title":["Prophylactic Antidepressant Treatment in Patients With Hepatitis C on Antiviral Therapy: A Double-Blind, Placebo-Controlled Trial"],"prefix":"10.1016","volume":"51","author":[{"given":"Benjamin J.","family":"Morasco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M.","family":"Loftis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Indest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Ruimy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Davison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradford","family":"Felker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0033-3182(10)70722-2_bib0005","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999\u20132002","volume":"144","author":"Armstrong","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0010","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/(SICI)1520-6394(1998)7:4<188::AID-DA7>3.0.CO;2-6","article-title":"Hepatitis C and depression","volume":"7","author":"Yates","year":"1998","journal-title":"Depress Anxiety"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/j.gastro.2005.11.011","article-title":"American Gastroenterological Association Technical Review on the Management of Hepatitis C","volume":"130","author":"Dienstag","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2893.2007.00887.x","article-title":"Old and emerging therapies in chronic hepatitis C: an update","volume":"15","author":"Deutsch","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0025","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1176\/appi.ajp.157.6.867","article-title":"Neuropsychiatric symptoms associated with hepatitis C and interferon \u03b1: a review","volume":"157","author":"Dieperink","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0030","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/mpr.229","article-title":"Methodological approaches in the assessment of interferon-alfa-induced depression in patients with chronic hepatitis C: a critical review","volume":"16","author":"Schafer","year":"2007","journal-title":"Int J Meth Psychiatr Res"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jad.2004.04.002","article-title":"The phenomenology and treatment of interferon-induced depression","volume":"82","author":"Loftis","year":"2004","journal-title":"J Affect Disord"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0040","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/sj.mp.4001119","article-title":"A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C","volume":"7","author":"Hauser","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0045","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11920-005-0042-3","article-title":"Neurobehavioral effects of interferon therapy","volume":"7","author":"Valentine","year":"2005","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0050","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM200103293441303","article-title":"Paroxetine for the prevention of depression induced by high-dose interferon alpha","volume":"344","author":"Musselman","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0055","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1176\/appi.psy.41.5.439","article-title":"Prophylactic treatment of depression induced by interferon-\u03b1","volume":"41","author":"Hauser","year":"2000","journal-title":"Psychosomatics"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1365-2893.2005.00554.x","article-title":"Prophylactic SSRIs during interferon \u03b1 re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression","volume":"12","author":"Kraus","year":"2005","journal-title":"J Viral Hepat"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0065","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2005.01.020","article-title":"Prevention of interferon-\u03b1 associated depression in psychiatric risk patients with chronic hepatitis C","volume":"42","author":"Schaefer","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jad.2007.01.007","article-title":"A randomized trial of paroxetine to prevent interferon-\u03b1-induced depression in patients with hepatitis C","volume":"103","author":"Morasco","year":"2007","journal-title":"J Affect Disord"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0075","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1365-2036.2007.03316.x","article-title":"Paroxetine for prevention of depressive symptoms induced by interferon-\u03b1 and ribavirin for hepatitis C","volume":"25","author":"Raison","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0080","series-title":"Structured Clinical Interview of DSM\u2013IV Axis I Disorders Clinician Version (SCID\u2013 CV)","author":"First","year":"1997"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0085","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0090","series-title":"Beck Depression Inventory Manual","author":"Beck","year":"1996"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0095","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0100","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/07357909509024923","article-title":"Treatment of neurotoxic side effects of interferon-\u03b1 with naltrexone","volume":"13","author":"Valentine","year":"1995","journal-title":"Cancer Invest"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0105","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4088\/JCP.v66n0814","article-title":"Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic\/hypomanic and depressive symptoms","volume":"66","author":"Constant","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0110","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1176\/appi.psy.44.2.104","article-title":"A prospective study of neuropsychiatric symptoms associated with interferon-\u03b1-2b and ribavirin therapy for patients with chronic hepatitis C","volume":"44","author":"Dieperink","year":"2003","journal-title":"Psychosomatics"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0115","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gut.2007.131607","article-title":"Therapy of interferoninduced depression in chronic hepatitis C with citalopram: a randomized, double-blind, placebo-controlled study","volume":"57","author":"Kraus","year":"2008","journal-title":"Gut"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00003495-200666020-00003","article-title":"Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management","volume":"66","author":"Loftis","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/S0033-3182(10)70722-2_bib0125","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2007.02.053","article-title":"Serotonin-1A receptor gene HTR1A variation predicts interferon-induced depression in chronic hepatitis C","volume":"132","author":"Kraus","year":"2007","journal-title":"Gastroenterology"}],"container-title":["Psychosomatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318210707222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318210707222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T20:14:42Z","timestamp":1713212082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033318210707222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":25,"aliases":["10.1176\/appi.psy.51.5.401"],"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0033318210707222"],"URL":"https:\/\/doi.org\/10.1016\/s0033-3182(10)70722-2","relation":{},"ISSN":["0033-3182"],"issn-type":[{"value":"0033-3182","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}